Big energy storage science is brewing at GSL just one year after its groundbreaking.

Ampcera has an exclusive licensing agreement with PNNL to commercially develop and license a new battery material for applications such as vehicles and personal electronics.

Lauren Charles, a chief data scientist at PNNL, showcased the vital research coming out of her program at The National Academies Forum workshop in Washington, D.C., January 15–16, 2025.

PNNL biodefense experts seek to identify, understand and mitigate the risks of biological pathogens—whether naturally occurring or intentionally created—so steps can be taken to prepare and respond.

Researchers will explore climate, pathogens and energy-efficient microelectronics using 3 million node hours on the nation’s supercomputers.

Research at PNNL and the University of Texas at El Paso are addressing computational challenges of thinking beyond the list and developing bioagent-agnostic signatures to assess threats.

Beyond melting ice and higher temperatures: On Earth Day, scientists consider how climate change will affect national security.

Scott Baker, the Functional and Systems Biology Group leader at PNNL, has been named to the American Institute for Medical and Biological Engineering's Class of 2024 Fellows.

Clean hydrogen energy infrastructure is coming to the Pacific Northwest with a newly announced hydrogen hub, and PNNL experts are advising the work to come.

DOE gives Hydrogen Program Special Award to PNNL's Hydrogen Safety Panel at department's 2023 Annual Merit Review and Peer Evaluation Meeting.

PNNL scientists investigate the promising properties of a common, Earth-abundant salt.

Microbes that were previously frozen in soils are becoming more active. This study demonstrates the diverse RNA viral communities found in thawed permafrost.

Steven Spurgeon’s research is featured in the cover of the MRS Bulletin along with his team’s invited perspective on the future of machine learning for electron and scanning probe microscopy.

Scientists can detect the virus that causes COVID-19 by using a bubble that spills its contents like a piñata when encountering the virus.

TransMED analyzes patient data from similar diseases across multiple sources to understand COVID-19 patient outcome risk factors.

The virus that causes COVID-19 takes over the body’s fat-processing system and boosts cellular triglycerides as it causes disease.

New facility will accelerate energy storage innovation, increase clean energy adoption and grid resilience.

Morris Bullock received an award and PNNL staff organized symposia and presented exciting research.

Surface characterization allows researchers to explore the compatibility between different solvent-membrane combinations.

PNNL scientists publish paper and host workshops to share threat-agnostic vision for biodefense.